Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency

Clinical trial NCT01312636 · COMPLETED

Trial details

NCT number: NCT01312636
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Congenital FVII Deficiency

Start date: 2011-03-01
Primary completion: 2014-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.